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Abstract
The Jackson Laboratory, having the world’s largest collection of mouse mutant stocks and genetically diverse inbred strains, is an
ideal place to look for genetically determined eye variations and disorders. Through ophthalmoscopy, electroretinography and
histology, we have discovered disorders aﬀecting all aspects of the eye including the lid, cornea, iris, lens and retina, resulting in corneal
disorders, cataracts, glaucoma and retinal degenerations.Mouse models of retinal degeneration have been investigated for many years
in the hope of understanding the causes of photoreceptor cell death. Sixteen naturally occurring mouse mutants that manifest de-
generation of photoreceptors in the retina with preservation of all other retinal cell types have been found: retinal degeneration
(formerly rd, identical with rodless retina, r, now Pde6brd1); Purkinje cell degeneration (pcd); nervous (nr); retinal degeneration slow
(rds, nowPrphRd2); retinal degeneration 3 (rd3); motor neuron degeneration (mnd); retinal degeneration 4 (Rd4); retinal degeneration 5
(rd5, now tub); vitiligo (vit, now Mitfmi-vit); retinal degeneration 6 (rd6); retinal degeneration 7 (rd7, now Nr2e3rd7); neuronal ceroid
lipofuscinosis (nclf); retinal degeneration 8 (rd8); retinal degeneration 9 (Rd9); retinal degeneration 10 (rd10, now Pde6brd10); and cone
photoreceptor function loss (cpﬂ1). In this report, we ﬁrst review the genotypes and phenotypes of these mutants and second, list the
mouse strains that carry each mutation. We will also provide detailed information about the cpﬂ1 mutation. The phenotypic charac-
teristics of cpﬂ1 mice are similar to those observed in patients with complete achromatopsia (ACHM2, OMIM 216900) and the cpﬂ1
mutation is the ﬁrst naturally-arising mutation in mice to cause cone-speciﬁc photoreceptor function loss. cpﬂ1 mice may provide a
model for congenital achromatopsia in humans.  2002 Elsevier Science Ltd. All rights reserved.
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1. Retinal degeneration 1 (Pde6brd1)
The ﬁrst retinal degeneration, and one of major
importance, is rd1 (formerly rd, identical with Keeler
rodless retina, r) (Keeler, 1966; Pittler, Keeler, Sidman,
& Baehr, 1993). This mutation has been found among
several common laboratory inbred strains, as well as
wild-derived inbred strains MOLD/Rk, MOLF/Ei, de-
rived from Mus musculus molossinus trapped in Japan;
SF/CamRk, SF/CamEi, derived from mice of Mus
musculus domesticus trapped in California; SK/CamEi,
derived from mice of Mus musculus domesticus trapped
on Skokholm Island oﬀ Pembrokeshire (Bonhomme &
Guenet, 1996). Mice homozygous for the rd1 mutation
have an early onset severe retinal degeneration due to a
murine viral insert and a second nonsense mutation in
exon 7 of the Pde6b gene encoding the beta subunit of
cGMP-PDE. Identity of the rd1 mutation as the Pde6b
gene was suggested by cosegregation of Pde6b with rd1
(Drager & Hubel, 1978); subsequently a nonsense mu-
tation in the Pde6b gene was identiﬁed in rd1 mice
(Pittler & Baehr, 1991), and so the allele symbol for rd1
is now Pde6brd1. The close linkage of the endogenous
xenotropic murine leukemia virus Xmv28 to Pde6b was
shown to arise from the integration of Xmv28 into the
ﬁrst intron of Pde6b in strains suﬀering from rd1 retinal
degeneration (Bowes et al., 1993). Since the rd1 muta-
tion is common in mice, it is important to avoid mouse
strains or stocks carrying the rd1 allele or exclude the
rd1 allele contamination in studying new retinal dis-
orders. Mice with the rd1 mutation can be easily typed
by phenotype based on vessel attenuation and pigment
patches in the fundus (Fig. 1, Hawes et al., 1999) and by
genotype with PCR for Dde I which reveals a RFLP
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Fig. 1. Fundus photographs of normal controls and various retinal degeneration mouse models. Vessel attenuation and optic atrophy are easily
detected signs that are often associated with retinal degenerations. C57BL/6J and BALB/cJ with normal fundus are used as control.
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(Pittler & Baehr, 1991). Mutations in the gene encoding
the b subunit of cGMP-PDE have been found in human
patients suﬀering from autosomal recessive retinitis
pigmentosa (OMIM 180072), a disorder bearing phe-
notypic resemblance to that caused by the mouse
Pde6brd1 mutation (McLaughlin, Sandberg, Berson, &
Dryja, 1993). An array of mutations in the catalytic
domain of the human homolog of Pde6b occurs in pa-
tients with retinitis pigmentosa (McLaughlin, Ehrhart,
Berson, & Dryja, 1995).
2. Purkinje cell degeneration (pcd)
The second, slower retinal degeneration discovered is
associated with Purkinje cell degeneration (pcd). pcd is an
autosomal recessive mutation that arose in the C57BR/
cdJ strain. Homozygotes show a moderate ataxia be-
ginning at 3–4 weeks of age and there is rapid degenera-
tion of nearly all Purkinje cells beginning at 15–18 days
of age. A slower degeneration of the photoreceptor cells
of the retina and mitral cells of the olfactory bulb also
occurs in pcd/pcd homozygotes (Mullen, Eicher, & Sid-
man, 1976). Pycnotic nuclei begin to appear in the pho-
toreceptor cells between 18 and 25 days of age, and the
outer rod segments become disorganized. Degeneration
of the photoreceptor cells proceeds slowly to complete-
ness over the course of a year (Blanks, Mullen, & LaVail,
1982; LaVail, Blanks, & Mullen, 1982). pcd was mapped
to mouse Chr 13; its human homolog should be on 5q. A
spontaneous remutation pcd (pcd2J , Purkinje cell de-
generation 2 Jackson, recessive) occurred in the SM/J
strain at The Jackson Laboratory in 1979. An insertion
of a 4.4 kb recombinant plasmid carrying an altered di-
hydrofolate reductase gene created an insertional muta-
tion with behavioral and pathologic features like those
of Purkinje cell degeneration. It is a recessive insertional
mutation named transgene insertional 1, Jon W. Gordon
(pcdJwg). Like pcd, it is characterized by rapid degenera-
tion of Purkinje cells and slower degeneration of retinal
photoreceptors and olfactory bulb mitral cells. Some
homozygous males are fertile, unlike pcd/pcd males. The
oﬀspring from a cross between a transgene heterozygote
and a pcd2J /pcd2J female displayed the mutant pheno-
type. The mutation has therefore been designated an
allele of pcd, pcdJwg (Neumann, Krulewski, & Gordon,
1989). Another remutation (Purkinje cell degeneration 3
Jackson, pcd3J ) arose on the BALB/cByJ strain at The
Jackson Laboratory. The new mutation was shown to be
an allele of pcd by a direct test for allelism.
3. Nervous (nr)
A third retinal degeneration was discovered in ner-
vous (nr) mice. The nr mutant arose spontaneously in a
BALB/cGr subline carrying tk (tail-kinks). Homozygous
nr mice may be recognized at 2–3 weeks by their smaller
size and hyperactive ataxic behavior. There is a 90% loss
of cerebellar Purkinje cells between 23 and 50 days.
Purkinje cell abnormalities are preceded by partial de-
generation of cells of the external granular layer (EGL)
at 6–8 days of age. In the retina, degeneration of the
photoreceptors is already present at 13 days. Whorls of
outer segment membranes form and the outer segments
eventually disappear completely (Sidman & Green,
1970; Mullen & LaVail, 1974). nr was mapped to mouse
Chr 8, and the human homolog should be on 8p or 13q.
4. Retinal degeneration 2 (Prph2Rd2)
The fourth retinal degeneration is retinal degenera-
tion-slow, formerly rds. Later it was found to be par-
tially dominant and so renamed Rds, and it has since
been renamed Rd2 in the retinal degeneration series
because its slow progression is no longer unique. A
mutation causing slow retinal degeneration was identi-
ﬁed in the 020/A inbred strain (van Nie, Ivanyi, & De-
mant, 1978). Homozygotes show retinal degeneration of
early onset and slow progression. Retinal photoreceptor
cells in these mutants lack outer segments that should
begin to develop by 7 days of age. At 2 weeks the outer
nuclear cell layer begins to degenerate slowly in mutant
animals. The ONL is gone by 9 months of age in the
peripheral retina and by 12 months in the central retina
(Sanyal, De Ruiter, & Hawkins, 1980; Jansen & Sanyal,
1984). The electroretinographic response is progressively
diminished with time and virtually extinguished by 12
months of age (Reuter & Sanyal, 1984). The mutation is
an insertion of foreign DNA into an exon of Prph2,
causing transcription of an abnormally large mRNA
(Ma et al., 1995). Mutations in the human gene for pe-
ripherin have been shown to cause slow retinal degen-
eration (OMIM 179605) similar to that caused by the
mouse Prph2Rd2 mutation (Travis & Hepler, 1993).
5. Retinal degeneration 3 (rd3)
A ﬁfth retinal degeneration is rd3. This spontaneous
autosomal recessive mutation that arose in the RBF/
DnJ strain at The Jackson Laboratory causes early
onset retinal degeneration. Development proceeds nor-
mally in rd3/rd3 homozygotes through the second
postnatal week. Thereafter, photoreceptor and outer
nuclear layers begin to degenerate, and by 8 weeks, no
photoreceptor cells remain. Changes in electroretino-
grams parallel the histologic changes. Intraspeciﬁc
crosses were used to map the rd3mutation to mouse Chr
1 in a region homologous to the region of human Chr 1q
to which Usher syndrome type IIA has been located
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(Chang, Heckinlively, Hawes, & Roberick, 1993). rd3
has been proposed as a candidate gene for orthology
to human USH2A (OMIM 276901), which causes a mild
form of Usher syndrome deafness. High frequency
progressive hearing loss was identiﬁed in RBF/DnJ
mice, but did not segregate with rd3; the latter is not,
therefore, the ortholog of USH2A (Pieke-Dahl, Oh-
lemiller, McGee, Walsh, & Kimberling, 1997). Genetic
and physical maps of the mouse rd3 locus also have
excluded the mouse ortholog of USH2A from the rd3
locus (Danciger, Danciger, Nusinowitz, Rickabaugh, &
Farber, 1999).
6. Motor neuron degeneration (mnd)
The sixth retinal degeneration was found in motor
neuron degeneration (mnd). The mnd mutation was
found in the C57BL/6.KB2/Rn (now B6.KB2-mnd/
MsrJ) congenic inbred strain. Mutants are characterized
by hindlimb weakness and ataxia that progresses to se-
vere spastic paralysis of all limbs from 5 to 11 months
of age, with death usually occurring by 9–14 months
(Messer & Flaherty, 1986; Messer, Plummer, Maskin,
Coﬃn, & Frankel, 1992). It is a good model for human
Batten disease and its expression is clearly recessive
(Bronson, Lake, Cook, Taylor, & Davisson, 1993). In
homozygous mnd mice, the retinal degeneration occurs
before neuromuscular dysfunction. The retinal degen-
eration is nearly complete by 6 months of age, when the
motor neuron abnormalities are just beginning. The
outer nuclear layer shows cell loss by 5 weeks of age. By
2 months, the peripheral retina is preferentially thinner
than the central retina, and by 6 months of age the entire
retina is reduced in thickness. The electroretinogram is
extinguished by 6 months of age. Transmission electron
microscopy at 3 and 6 months of age showed distinct
cytoplasmic inclusions characteristic of the curvilinear
proﬁles seen in human ceroid lipofuscinosis. Genetic
analysis showed that the retinal degeneration in mnd
mice is inherited as a single autosomal gene with reces-
sive expression and is mapped to the proximal end of
mouse Chr 8 (Chang et al., 1994) and a human homolog
should be on 8p or 13q.
7. Retinal degeneration 4 (Rd4)
A seventh retinal degeneration is Rd4. This autoso-
mal dominant retinal degeneration was found in a stock
carrying the chromosomal inversion In(4)56Rk, which
was induced in a DBA/2J male. The inversion is ho-
mozygous lethal and in heterozygotes is always associ-
ated with retinal degeneration. In aﬀected mice, the
retinal outer nuclear layer thickness begins to decrease
at 10 days of age, showing total loss at 6 weeks. The
recordable electroretinograms are poor between 3 and 6
weeks and are barely detected thereafter. Retinal vessel
attenuation, pigment spots, and optic atrophy appear in
the fundus at 4 weeks of age. Rd4 has not recombined
with the inversion in an outcross, suggesting that the
Rd4 locus is located very close to or is disrupted by one
of the breakpoints of the inversion on Chr 4 (Roderick,
Chang, Hawes, & Heckinlively, 1997). Analysis of the
backcross data placed the inversion breakpoints within 1
cM of the telomere and 7 cM of the centromere. FISH
analysis narrowed the region in which the breakpoint
lies at the distal end of the chromosome and showed that
the proximal breakpoint is in the centromere itself.
Therefore, the Rd4 gene must be disrupted by the telo-
meric breakpoint of the inversion. The telomeric region
of mouse Chr 4 is homologous to human 1p36. No in-
herited retinal diseases have been identiﬁed previously in
either of these chromosomal regions. Therefore, the Rd4
gene is novel and necessary for the normal integrity
and function of the mouse retina. Its identiﬁcation will
provide another candidate gene for the site of mutations
responsible for inherited human retinal degenerations
(Danciger et al., 2000).
8. Retinal degeneration 5 (rd5)
An eighth retinal degeneration is rd5. rd5 was found
in C57BL/6J-tub, now a subline of C57BL/6J wherein
a mutation to tubby (tub) occurred in 1977. Indirect
ophthalmoscopy reveals arteriolar attenuation, venous
dilation, and granular appearance in the fundus by six
weeks of age. By ﬁve months there is retinal vessel at-
tenuation and loss of pigment epithelium. At this time,
patches of pigment deposits are clear. The electroretino-
grams in the homozygous rd5/rd5 mouse are never
normal with reduced amplitudes that extinguish by 6
months. tub/tub mice combine retinal degeneration and
progressive hearing loss. The hearing loss is due to de-
generation of the organ of Corti and loss of aﬀerent
neurons (Heckenlively et al., 1995). The retinal degen-
eration aspects of tub homozygotes have been presented
as a mutant gene, rd5, but tub and rd5 are the same gene
(Noben-Trauth, Naggert, North, & Nishina, 1996). The
involvement of tub in obesity, retinal degeneration, and
hearing loss suggests it as a model for the Alstrom
(OMIM 203800) or Bardet-Biedl (OMIM 209900) syn-
dromes (Noben-Trauth et al., 1996).
9. Vitiligo (vit, now Mitf mi-vit)
The ninth retinal degeneration was found in vitiligo
mice. A spontaneous mutation in C57BL/6J mice causes
lighter initial coat color than normal, with extensive
white spotting. After eight weeks of age, the mice pro-
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duce increasing numbers of white hairs with each molt,
thus phenotypically resembling human vitiligo (Lerner,
1986). The vitiligo mutation was mapped to Chr 6 near
Mitf (Tang, Neumann, Kosaras, Taylor, & Sidman,
1992), and lack of complementation between vitiligo and
MitfMi-wh was shown (Lamoreux, Boissy, Womack, &
Nordlind, 1992), establishing vitiligo as a mutation in
the Mitf gene (Mitfmi-vit). An amino acid substitution in
the ﬁrst helix is the molecular lesion (Steingrimsson
et al., 1994). Mitfmi-vit homozygotes show a slow pro-
gressive loss of photoreceptor cells, cosegregating with
the gradual depigmentation (Smith & McCool, 1995).
The outer plexiform layer is signiﬁcantly thinner by 4
months and the rows of photoreceptor cells are lost at a
rate of about one per month beginning at 2 months of
age. By 8 months, the photoreceptor cell nuclei have
diminished to only two to three rows (Smith, 1995).
Furthermore, retinal detachment from the RPE, the
displacement of darkly-staining cells into the subretinal
space and the inﬂux of macrophage-like cells in the area
of the retina outer segment (ROS) are present in
Mitfmi-vit/Mitfmi-vit mice (Smith, Cope, & McCoy, 1994).
A depigmented area and star patterns appear in the
fundus of Mitfmi-vit/ Mitfmi-vit mice (Fig. 1).
10. Retinal degeneration 6 (rd6)
The tenth retinal degeneration is rd6. rd6 is associated
with distinctive white dots or retinal ﬂecks (Chang et al.,
1996). The inheritance pattern of rd6 is autosomal re-
cessive and it maps to mouse Chr 9 about 24 cM from
the centromere, suggesting the human homolog may be
on Chr 11q23. Ophthalmoscopic examination of mice
homozygous for rd6 reveals discrete subretinal spots
oriented in a regular pattern across the retina. The ret-
inal spots appear clinically by 8–10 weeks of age and
persist through advanced stages of retinal degeneration.
Histologic examination reveals large cells in the subre-
tinal space, typically juxtaposed to the retinal pigment
epithelium. The white dots seen on fundus examination
correspond both in distribution and size to these large
cells. By three months of age, the cells are ﬁlled with
membranous proﬁles, lipofuscin-like material, and pig-
ment. These cells react strongly with an antibody di-
rected against a mouse macrophage-associated antigen.
Photoreceptor cells progressively degenerate with age
and an abnormal electroretinogram is initially detected
between one and two months of age (Hawes et al., 2000).
11. Retinal degeneration 7 (rd7)
An eleventh retinal degeneration is rd7. The rd7
mutation was found by histological examination of a
mouse stock carrying multiple coat color genes (Tyrp1b/
Tyrp1b, ln/ln, a/a) called 77-2 C2a special at The Jackson
Laboratory. Light microscopy shows retinal waves,
whorls, and rosettes that increase and decrease concor-
dant with retinal spots and the later onset photoreceptor
degeneration. Electroretinograms show an initial atten-
uation of a- and b-waves compared to controls, which
remains stable to about one year of age at which time
progressive amplitude loss resumes (Chang, Hecken-
lively, Hawes, & Davisson, 1998). A 380-nt deletion
from the coding region of a photoreceptor-speciﬁc nu-
clear receptor gene, Nr2e3, causes retinal abnormalities
in rd7 mice. In normal mice, the deleted nucleotides
encode 127 amino acids that are part of the DNA-
binding domain of the protein NR2E3, and encompass
ca. 32% of its length. The deletion causes a frame shift
resulting in a premature stop codon. Our results demo-
nstrate that NR2E3 expression is critical for the in-
tegrity and function of mouse photoreceptor cells
(Akhmedov et al., 2000).
12. Neuronal ceroid lipofuscinosis (nclf )
The twelfth retinal degeneration was found in the
neuronal ceroid lipofuscinosis (nclf) mutant mouse. The
nclf mutation arose in a mixed genetic background that
includes C57BL/6J, C57BL/10J, and C3HeB/FeJLe.
nclf/nclf mice develop progressive ataxia, myelination
defects, neurodegeneration, neuromuscular defects and
retinal degeneration. Paralysis and death occur by
around 9 months of age (Bronson et al., 1998). nclfmaps
to Chr 9. This suggests homology to the human CLN6
(OMIM 601780) gene on Chr 15q, encoding a late in-
fantile variant of ceroid lipofuscinosis (Bronson et al.,
1998). In homozygous nclf mice, the outer nuclear layer
shows cell loss by four months after birth. By 6 months
the peripheral outer retina is severely aﬀected, and by 9
months the entire retina is atrophied. The electroretino-
gram and light histology ﬁndings correlate well.
13. Retinal degeneration 8 (rd8)
A thirteenth retinal degeneration is rd8. Mice ho-
mozygous for rd8 show slow retinal degeneration with
large white retinal deposits covering the inferior quad-
rant of the retina. Histology at 5 weeks of age shows
areas of retinal folding that correspond to the white
retinal spots. Electroretinograms demonstrate initial
attenuation of the a- and b-waves compared to normal
controls. ERGs remain relatively stable for one year, at
which time further progressive amplitude loss is noted.
Genetic analysis shows that this disorder is caused by an
autosomal recessive mutation that maps to mouse Chr 1
(Chang et al., 1999).
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Table 1
Mouse strains with diﬀerent retinal degenerations
Gene Chromosome Retinal ONL
loss by (month)
Strains
Mouse Human
Pde6brd1 5 4p16 1 ABJ/Le; BDP/J; BUB/BnJ; C3H and all substrains; CBA/J;
CBA/NJ; FVB/NJ; JGBF/Le; MOLD/Rk; MOLF/Ei; NFS/N;
NON/LtJ; P/J; PL/J; RSV/Le; SB/Le; SF/CamEi; SF/CamRk;
SK/CamEi; ST/bJ; SJL/J; SWR/J; WB/ReJ; WC/ReJ
pcd 13 5q 13 B6.BR-pcd; B6C3Fe-a/a-pcd/+; BALB/cByJ-pcd3J
nr 8 8p or 13q 10 BALB/cByJ-nr; C3Fe.CGr-nr
Prph2Rd2 17 6p 12 O20/A; C3.BLiA-Prph2Rd2
rd3 1 1q32 4 RBF/DnJ; Stock Rb4Bnr; RBJ/Dn; Stock In30Rk
mnd 8 8p or 13q 6 B6.KB2-mnd/MsrJ
Rd4 4 1p36 2 Stock In56Rk Rd4
rd5(tub) 7 11p15 8 C57BL/6J-tub/+
Mitfmi-vit 6 3p14 10 C57BL/6J-Mitfmi-vit
rd6 9 11q23 24 B6.C3Ga-rd6/rd6;
Nr2e3rd7 9 15q23 30a 77-2C2a-special; Stock Nr2e3rd7
nclf 9 15q21 13 B6.Cg-nclf; Stock a/a nclf/nclf
rd8 1 1q25 30b Stock rd8
Rd9 X Xp21.1 30 C57BL/6J-Rd9
Pde6brd10 5 4p16 2 Stock Pde6brd10
cpﬂ1 19 10q25 30c Stock cpﬂ1
a rd7/rd7 Mice have a 5-cell layer in ONL at 16 months of age and still have a 5-cell layer when mice reach 30 months of age.
b rd8/rd8 Mice lose ONL only in disease areas.
c cpﬂ1/cpﬂ1 Mice lose only cone cells.
Fig. 2. Composite showing histologic sections of retinal degenerations. The top left shows a normal retina from C57BL/6J mouse at 3 months of age,
the top middle shows a thinning outer nuclear layer loss in the retina from a rd1/rd1 mouse at 21 days of age and top right shows thin outer nuclear
layer in the retina from a rd10/rd10 mouse at 23 days of age (right). The bottom left shows outer nuclear layer (ONL) waves and one aberrant RPE-
like cell in the subretinal space from a rd6/rd6 mouse at 7 months of age and the bottom right shows photoreceptor and outer nuclear layer waves,
whorls, and rosettes in the retina from a rd7/rd7 mouse at 1 month of age.
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14. Retinal degeneration 9 (Rd9)
A fourteenth retinal degeneration is Rd9. Rd9 is an
X-linked semidominant retinal degeneration model. In
Rd9 mutants, the retina is covered with diﬀuse white
spots (mottled). The fundus appears normal at weaning
age and the retina becomes mottled starting at 6 weeks
of age in heterozygous females. The fundus of homo-
zygous females and hemizygous males have a blond
appearance. Retinal pigment loss and electroretinogram
response decreases with age (Chang et al., 1999).
15. Retinal degeneration 10 (rd10)
A ﬁfteenth retinal degeneration is rd10. Mice homo-
zygous for the rd10 mutation show retinal degeneration
with sclerotic retinal vessels at 4 weeks of age. Histology
at 3 weeks of age shows retinal degeneration. Elec-
troretinograms of rd10/rd10 mice are never normal. The
maximal response occurs at 3 weeks of age and is non-
detectable at 2 months of age. Genetic analysis shows
that this disorder is caused by an autosomal recessive
mutation that maps to mouse Chr 5. Sequence analysis
shows that the retinal degeneration is caused by a mis-
sense mutation in exon 13 of the beta subunit of the rod
phosphodiesterase gene. Therefore, the gene symbol for
the rd10 mutation is now Pde6brd10. The exon 13 mis-
sense mutation is the ﬁrst known occurrence of a re-
mutation in the Pde6b gene in mice and may provide a
good model for studying the pathogenesis of autosomal
recessive retinitis pigmentosa (arRP) in human. It may
also provide a better model than Pde6brd1 for experi-
mental pharmaceutical-based therapy for RP because
of its later onset and milder retinal degeneration (Chang
et al., 2000).
16. Cone photoreceptor function loss (cpﬂ1)
The sixteenth retinal degeneration is the cone pho-
toreceptor function loss 1 (cpﬂ1) mutation. Mice ho-
mozygous for the cpﬂ1 mutation have a normal fundus.
Electroretinograms of cpﬂ1/cpﬂ1 mice show no cone-
mediated photoresponse but normal rod-mediated
photoresponses from 3 weeks to 15 months of age.
Histological results from cpﬂ1/cpﬂ1 mice at parallel ages
show an overall normal retinal structure with cone
photoreceptor cell degeneration. Cone cell numbers are
reduced and progressively diminish with age compared
to wild-type control. However, the remaining cones
appear structurally normal by electron microscopy.
Genetic analysis shows that this disorder is caused by an
autosomal recessive mutation that maps to mouse Chr
19. Although cone photoreceptor cells are functionally
defective at the earliest age when testing is possible, the
Fig. 3. Electroretinograms (ERGs) of a C57BL/6J mouse with a normal rod and cone ERG response on the left, cpﬂ1/cpﬂ1mouse with a normal rod
and a bad cone response on the middle and rd10/rd10 mouse with a bad rod and a good cone response on the right.
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rod photoreceptor cells and rod-mediated photore-
sponses are completely intact in the cpﬂ1 mice. The
phenotypic characteristics of cpﬂ1 mice are similar to
those observed in patients with complete achromatopsia
(ACHM2, OMIM 216900). The cpﬂ1 mutation is the
ﬁrst naturally-arising mutation in mice to cause cone
photoreceptor function loss and it may provide a model
for congenital achromatopsia in human (Chang et al.,
2001).
17. Summary
Table 1 summarizes the progression of retinal de-
generations for all sixteen mutations and lists the
available mouse strains carrying each mutation. Fig. 1
shows some typical fundus appearances seen in normal
retina and diseased retina. Fig. 2 shows some histologi-
cal sections of normal and degenerating retinas. Fig. 3
shows some electroretinograms from a normal mouse
and mice with retinal degeneration. Although the end
point in retinal degeneration is very similar in appear-
ance among the mutations, there is richness in variation
of onset and progression, oﬀering opportunities for
study and experiments to ameliorate the conditions.
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